Skip to content

Adar1 Capital Management portfolio · Q3 2026

ADAR1 Capital Management, LLC · CIK 0001940272 ·13F filings on SEC EDGAR

In Q3 2026, ADAR1 Capital Management, LLC reported 272 positions worth $2.3B. Its largest holding was ABVX at 8.6% of the portfolio, and the top 10 made up 39%. Its largest new position was FRNM ($25.9M), and it sold out of CRNX.

Portfolio value
$2.3B
Positions
272
Top 10 share
38.7%
Changes vs Jun 30, 2026
  • NEW 45
  • ADD 85
  • REDUCE 60
  • EXIT 50

Portfolio map

NEWADDHOLDREDUCE

Each box is a position sized by its value. Color shows the change in shares from the previous quarter. The smallest 232 positions are grouped as one box.

Portfolio history

Q4 2025 to Q3 2026, 4 quarters

Weight of the largest holdings

The 7 holdings with the highest weight in any quarter shown, stacked with all others to 100%.

ABVXPTGXSPYROIVIMVTZLABRNAMOther

Holding timeline

Shade shows the weight in each quarter. A blank cell means the holding was not reported that quarter.

< 1%1–3%3–6%6–10%10–20%20–35%≥ 35%

Holdings

Click a holding to see its price chart with the quarters the investor bought or sold.

NameWeightAvg. cost (est.)Latest priceGain/lossValue
92686JAA4
VIKING THERAPEUTICS INC
PRN
0.42%———$10M
PRAXCall
PRAXIS PRECISION MEDICINES I
0.37%———$8.7M
ABVXCall
ABIVAX SA-ADR
0.30%———$6.9M
10806XAD4
BRIDGEBIO PHARMA INC
PRN
0.20%———$4.6M
10806XAJ1
BRIDGEBIO PHARMA INC
PRN
0.19%———$4.5M
10806XAB8
BRIDGEBIO PHARMA INC
PRN
0.13%———$3.1M
04280AAC4
ARROWHEAD PHARMACEUTICALS IN
PRN
0.04%———$1M
IOVAPut
IOVANCE BIOTHERAPEUTICS INC
0.03%———$741K
23282WAE0
CYTOKINETICS INC
PRN
0.03%———$621.2K
RARECall
ULTRAGENYX PHARMACEUTICAL IN
0.01%———$300.6K

Average cost is an estimate, not the investor's actual purchase price: every quarter the share count rose, the added shares are counted at that quarter-end's 13F price, and sales keep the average. Latest price is the most recent 13F quarter-end price (Sep 30, 2026), and value is shares × latest price. * Held since before Dec 31, 2023, when our collected history starts, so the average starts from that quarter's price.

Changes in shares

Change in shares held vs Jun 30, 2026, for the 20 largest positions that changed. Bars are capped at ±100%; the label shows the actual change.

NEWADDREDUCEEXIT

Sold out this quarter

Held on Jun 30, 2026 and not reported for Q3 2026.

StockPrior weightPrior sharesPrior valueChange
CRNX
CRINETICS PHARMACEUTICALS IN
2.09%1,222,080$45.7MEXIT
IWMPut
ISHARES RUSSELL 2000 ETF
0.86%62,500$18.8MEXIT
SPYPut
SS SPDR S&P 500 ETF TRUST-US
0.85%25,000$18.7MEXIT
XBIPut
SS SPDR S&P BIOTECH ETF
0.49%67,400$10.7MEXIT
881624209
TEVA PHARMACEUTICAL INDS LTD
0.43%277,848$9.4MEXIT
FTH
FAETH THERAPEUTICS INC
0.41%361,010$9MEXIT
FRNM
FREENOME INC
0.34%674,695$7.3MEXIT
36322Q206
DAMORA THERAPEUTICS INC
0.33%280,000$7.3MEXIT
BHF
BRIGHTHOUSE FINANCIAL INC
0.28%95,523$6MEXIT
ATAI
ATAIBECKLEY INC
0.22%913,242$4.8MEXIT
PRLD
PRELUDE THERAPEUTICS INC
0.22%900,900$4.8MEXIT
APGE
APOGEE THERAPEUTICS INC
0.19%31,000$4.1MEXIT
SGMT
SAGIMET BIOSCIENCES INC-A
0.15%437,500$3.4MEXIT
OABI
OMNIAB INC
0.11%947,412$2.3MEXIT
ORKA
ORUKA THERAPEUTICS INC
0.09%20,840$2MEXIT
92941V308
VYNE THERAPEUTICS INC
0.09%2,950,000$1.9MEXIT
MCK
MCKESSON CORP
0.09%2,500$1.9MEXIT
AVTR
AVANTOR INC
0.06%130,000$1.3MEXIT
457637700
INMED PHARMACEUTICALS INC
0.06%800,000$1.2MEXIT
23255M204
CYCLERION THERAPEUTICS INC
0.05%298,757$1MEXIT
EA
ELECTRONIC ARTS INC
0.05%4,936$1MEXIT
89422GAB3
TRAVERE THERAPEUTICS INC
0.05%10,000$1MEXIT
ACAD
ACADIA PHARMACEUTICALS INC
0.05%38,955$985.6KEXIT
DYN
DYNE THERAPEUTICS INC
0.04%42,821$951.1KEXIT
KVACFCall
KEEN VISION ACQUISITION CORP
0.04%75,000$930KEXIT
Y95308105
WAVE LIFE SCIENCES LTD
0.04%160,000$929.6KEXIT
NUVL
NUVALENT INC-A
0.04%6,942$857.3KEXIT
ADGM
ADAGIO MEDICAL HOLDINGS INC
0.04%1,205,447$785.5KEXIT
AMLXPut
AMYLYX PHARMACEUTICALS INC
0.03%40,100$720.2KEXIT
FWRD
FORWARD AIR CORP
0.03%48,241$651.7KEXIT
SYK
STRYKER CORP
0.03%2,000$629.7KEXIT
NVOCall
NOVO-NORDISK A/S-SPONS ADR
0.03%13,000$623.2KEXIT
IOVA
IOVANCE BIOTHERAPEUTICS INC
0.03%146,090$607.7KEXIT
CRBPCall
CORBUS PHARMACEUTICALS HOLDI
0.03%60,000$562.8KEXIT
23256X407
CYBIN INC
0.02%81,278$537.2KEXIT
BNTC
BENITEC BIOPHARMA INC
0.02%40,000$535.2KEXIT
KIDS
ORTHOPEDIATRICS CORP
0.02%25,000$478.3KEXIT
MRK
MERCK & CO. INC.
0.02%3,140$403.5KEXIT
ANAB
ANAPTYSBIO INC
0.01%3,698$249.6KEXIT
BCYC
BICYCLE THERAPEUTICS PLC-ADR
0.01%50,638$214.7KEXIT
PSNL
PERSONALIS INC
0.01%15,000$201KEXIT
QCLS
Q/C TECHNOLOGIES INC
0.01%50,000$195KEXIT
CMMB
CHEMOMAB THERAPEUTICS LTD
0.01%80,000$129.6KEXIT
STICall
SOLIDION TECHNOLOGY INC
0.01%13,500$125.4KEXIT
TRDA
ENTRADA THERAPEUTICS INC
0.01%15,500$114.1KEXIT
VTGN
VISTAGEN THERAPEUTICS INC
0.00%351,141$79.4KEXIT
54303L203
LONGEVERON INC
0.00%108,406$76.2KEXIT
471871202
JASPER THERAPEUTICS INC
0.00%140,000$58.9KEXIT
38341P102
GOSSAMER BIO INC
0.00%212,531$35KEXIT
002120202
ATYR PHARMA INC
0.00%50,685$30.2KEXIT

SEC filings for Q3 2026